Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Ann Surg Oncol. 2015 Apr 24;22(13):4402–4410. doi: 10.1245/s10434-015-4566-4

Figure 3. Autophagic response to treatment predicts improved outcome following pre-operative Gemcitabine/HCQ.

Figure 3

LC3 punctate staining was evaluated by immunoflourescence in circulating peripheral blood mononuclear cells (PBMCs) before and after treatment (a). Patients with a greater than 51% increase in LC3 puncta (LC3-II Response) had improved disease free (b) and overall survival (c).